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ABSTRACT
A polyguanine/polycytosine (polyG/polyC) tract in
the proximal promoter of the vascular endothelial
growth factor (VEGF) gene is essential for transcrip-
tional activation. The guanine-rich (G-rich) and
cytosine-rich (C-rich) strands on this tract are
shown to form specific secondary structures, char-
acterized as G-quadruplexes and i-motifs, respec-
tively. Mutational analysis of the G-rich strand
combined with dimethyl sulfate (DMS) footprinting,
a polymerase stop assay, and circular dichroism
(CD) spectroscopy revealed that the G-quadruplex
containing a 1:4:1 double-chain reversal loop is the
most thermodynamically stable conformation that
this strand readily adopts. These studies provide
strong evidence that the size of loop regions plays
a critical role in determining the most favored fold-
ing pattern of a G-quadruplex. The secondary struc-
ture formed on the complementary C-rich strand
was also determined by mutational analysis com-
bined with Br2 footprinting and CD spectroscopy.
Our results reveal that at a pH of 5.9 this strand is
able to form an intramolecular i-motif structure that
involves six C–C
+ base pairs and a 2:3:2 loop con-
figuration. Taken together, our results demonstrate
that the G-quadruplex and i-motif structures are
able to form on the G- and C-rich strands, respec-
tively, of the polyG/polyC tract in the VEGF proximal
promoter under conditions that favor the transition
from B-DNA to non-B-DNA conformations.
INTRODUCTION
VEGF, a key regulator of angiogenesis, plays an impor-
tant role in tumor survival, growth and metastasis (1,2)
and is overexpressed in many types of human cancers,
including glioma, renal cell carcinoma, and ovarian and
pancreatic cancer (3–6). VEGF expression is regulated by
many external stimuli, such as hypoxia (7–9), growth fac-
tors (10,11), hormones (12) and cytokines (13,14). Also,
the loss or inactivation of tumor suppressor genes (15,16)
and the activation of oncogenes (17) are reported to cause
VEGF upregulation. Studies on the molecular mechanism
of VEGF gene expression have deﬁned major cis-acting
elements and transcription factors involved in the regula-
tion of this expression (18–20). These studies showed that
a polyG/polyC tract in the VEGF proximal promoter
region (–85 to –50bp relative to the initiation of transcrip-
tion; Figure 1) is essential for basal and inducible VEGF
expression. This polyG/polyC tract contains three poten-
tial Sp1 binding sites (Figure 1). It was reported that the
deletion of this polyG/polyC tract dramatically decreases
the basal promoter activity by about 90% and abolishes
VEGF expression induced by platelet-derived growth
factor (PDGF) in NIH3T3 cells (18). In another report,
the deletion of this polyG/polyC tract totally abrogated
VEGF promoter activity in PANC-1 cancer cells (19).
Given the importance of this tract for VEGF promoter
activity, we examined the DNA sequence of this region
and found that the G-rich strand contains four con-
secutive runs of guanines separated by one or
two cytosine bases, and the C-rich strand contains four
consecutive runs of cytosines separated by one or two
guanine bases. These sequences are consistent with the
*To whom correspondence should be addressed. Tel: +1 520 626 0323; Fax: +1 520 626 4824; Email: sun@pharmacy.arizona.edu
Correspondence may also be addressed to Laurence Hurley. Tel: +1 520 626 5622; Fax: +1 520 626 4824; Email: hurley@pharmacy.arizona.edu
 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.general motifs that form G-quadruplex and i-motif
structures.
DNA sequences containing consecutive runs of gua-
nines are known to form intermolecular or intramolecular
G-quadruplex structures. These are four-stranded struc-
tures consisting of stacked G-tetrads having a planar asso-
ciation of four guanines held together by Hoogsteen
hydrogen bonding (21–25). DNA sequences containing
consecutive runs of cytosines, at acidic pH levels, are
capable of forming intermolecular or intramolecular
four-stranded i-motif structures. The two parallel-
stranded C–C
+ (one cytosine must be hemiprotonated
at the N3 position) base-paired duplexes intercalate into
each other in an antiparallel orientation. G-quadruplex
and i-motif structures have been extensively studied and
have been shown to form in the telomeric ends of eukary-
otic chromosomes (26–30) and in the G- and C-rich
sequences located in the proximal promoter regions of
c-myc (21,31,32), KRAS (30,33), Rb (34) and RET (35)
genes. In the present study, we demonstrate the formation
of these structures in the VEGF promoter.
Within supercoiled plasmid DNA, the G-rich strand in
the polyG/polyC tract of the VEGF proximal promoter is
very dynamic and able to adopt non-B-DNA conforma-
tions, which are resistant to cleavage by both DNase I and
S1 nuclease in the presence of K
+ or the G-quadruplex-
interactive agent telomestatin (36,37). The G-rich strand
of the VEGF proximal promoter contains ﬁve runs of
guanines (Figure 1). Our previous work has shown that
the four 50-end runs of guanines are involved in the for-
mation of an intramolecular G-quadruplex, whereas inclu-
sion of the ﬁfth run of guanines results in the formation of
intermolecular G-quadruplexes (37). Therefore, we
focused this study on the presumably more biologically
relevant G-quadruplex formed by the ﬁrst four runs of
guanines at the 50-end. Results from a polymerase stop
assay and CD studies of the G-rich strand in this region
show the formation of an intramolecular parallel G-quad-
ruplex structure (36). The most thermodynamically stable
G-quadruplexes formed by the G-rich strand in the VEGF
proximal promoter were studied using mutational analy-
sis, CD melting, DMS footprinting and a polymerase stop
assay. This present investigation has added signiﬁcance
since we have recently shown that the G-quadruplex-
interactive agents that are able to stabilize these
G-quadruplexes repress VEGF expression in cancer cells,
which oﬀers a new approach to antiangiogenesis therapy.
Here, we demonstrate the formation of both G-qua-
druplex and i-motif structures in the VEGF proximal pro-
moter and characterize their folding patterns and most
likely structures using biochemical and biophysical tech-
niques. Finally, other sequences in promoter regions that
form these G-quadruplex and i-motif structures have been
compared to provide additional insight into the conserva-
tion of these elements.
MATERIALS AND METHODS
Materials
The oligonucleotides used in this work were purchased
from Biosearch Technologies (Novato, CA, USA), and
their sequences are listed in Table 1.
CD spectroscopy
CD spectra were recorded on a Jasco-810 spectropho-
tometer (Jasco, Easton, MD, USA) at room temperature
( 258C), using a quartz cell of 1mm optical path length,
an instrument scanning speed of 100nm/min, with a
response time of 1s and over a wavelength range of
200–350nm. Each spectrum was recorded three times,
smoothed and baseline-corrected for signal contributions
from used buﬀers.
For the G-quadruplex study, the oligonucleotides were
diluted to a strand concentration of 10mM in 50 mM Tris–
HCl, pH 7.4, with an appropriate concentration of KCl.
In the Tm experiment with 20mM KCl, the molar ellipti-
cities at 262nm at diﬀerent temperatures (4–958C) were
recorded and plotted against temperatures.
Table 1. Oligonucleotides used in this study
Bold letters indicate mutated bases.
Figure 1. Schematic diagram of the proximal promoter region of the
human VEGF gene, with the location and base sequence of the polyG/
polyC tract in this region shown. Three Sp1 binding sites are enclosed
in boxes, and the four runs of guanines are underlined. The DNase I
and S1 nuclease hypersensitive sites are indicated with ﬁlled circles and
arrowheads, respectively.
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to a strand concentration of 10mM in 50 mM Tris–acetate
at appropriate pHs. To determine the transition mid-point
of the VEGF i-motif structure, the molar ellipticities at
288nm against pHs were plotted and the mid-point was
determined.
DMSfootprinting
The oligonucleotides were 50-end-labeled with
32P and
puriﬁed by micro-spin column 6. The
32P-labeled oligonu-
cleotides were treated with 2% DMS for 5min in either
the absence of KCl or the presence of 100mM KCl. The
DMS-treated oligonucleotides were loaded on a 16% non-
denaturing polyacrylamide gel to separate the single-
stranded DNA and intramolecular G-quadruplex from
other intermolecular G-quadruplexes by their diﬀerent
electrophoretic mobilities. The DNA were recovered and
subjected to piperidine cleavage (21).
Polymerase stopassay
The polymerase stop assay templates were designed by
placing the VEGF proximal promoter G-rich sequence,
or the various mutant G-rich sequences, in a polymerase
stop assay cassette, as described previously (38). 50-end-
labeled primer p28d(TAATACGACTCACTATAGCAA
TTGCGTG) and template DNA were annealed in an
annealing buﬀer (50mM Tris–HCl, pH 7.5, 10mM NaCl)
by heating at 958C for 5min and slowly cooling to room
temperature. The primer-annealed template oligonucleo-
tides were puriﬁed by electrophoresis using a 12% nonde-
naturing polyacrylamide gel. The puriﬁed primer
template oligonucleotides were used in a primer
extension assay with Taq DNA polymerase, as described
previously (38).
Native polyacrylamide gelelectrophoresis (PAGE)
The pHs of PAGE gel solution in 1 Tris–Acetate–
EDTA and running buﬀer (1 Tris–acetate–EDTA)
were both adjusted to pH 5.0. Ten thousand cpm of
32P-
labeled IM1 or T24 in 50 mM Tris–acetate, pH 5.0, was
heated at 958C for 5min, cooled to room temperature and
incubated at room temperature for 2h before loading on a
20% nondenaturing PAGE gel.
Br2 footprinting experiment
The Br2 footprinting experiment was carried out in
accordance with published procedure (39) to probe the
secondary structure formed by IM1. In brief, IM1 was
50-end-labeled with
32P using T4 polynucleotide kinase
and [g-
32P] ATP, and the labeled IM1 was gel-puriﬁed
using 12% polyacrylamide gel electrophoresis under dena-
turing conditions(7M urea). For the Br2cleavage reaction,
the puriﬁed 50-end-labeled IM1 was treated for 20min with
molecular Br2 that was generated in situ by mixing an equal
molar concentration (50 mM) of KBr with KHSO5 in the
same tube. The reactions were then terminated by adding
50ml of stop mix containing 0.6M Na-acetate (pH 5.2) and
10mg/ml calf thymus DNA, and unreacted Br2 was
removed by ethanol precipitation. Following ethanol
precipitation, the DNA pellet was dried and resuspended
with 100ml of freshly diluted 1M piperidine, and the sam-
ples were heated at 908C for 30min to induce bromination-
speciﬁc strand cleavage. Following piperidine treatments,
the DNA samples were completely dried and resuspended
with alkaline sequencing gel loading dye and applied to a
20% sequencing gel. The purine- and pyrimidine-speciﬁc
reactionswerecarriedoutusingformicacidorhydrazineto
generate sequencing markers, following published proce-
dure (39).
RESULTS
Formation of G-quadruplexstructures in theG-rich strand
of theVEGF proximal promoter
We have reported that the G-rich strand of the VEGF
proximal promoter is able to form an unusual DNA sec-
ondary structure in the presence of KCl or G-quadruplex-
interactive-agents, such as TMPyP4 and telomestatin (36).
In the presence of 100mM KCl, the CD spectrum of the
wild-type G-rich sequence in the VEGF proximal promo-
ter (WT, Table 1A) exhibits a characteristic positive peak
at 264nm and a negative peak at 240nm, suggesting that it
forms a parallel G-quadruplex structure (Figure 2A)
(35,36). In the sequences studied, we added 50 and 30
thymidine tails and showed that these did not aﬀect the
folding patterns relative to the native sequences.
To resolve the G-quadruplex structure formed by this
strand, we performed DMS footprinting to identify gua-
nines involved in the G-tetrads, by their resistance to
methylation at position N7 due to Hoogsteen hydrogen
bonding (21). In this process, the G-quadruplex-forming
oligonucleotides were subjected to DMS treatment in the
absence or presence of KCl. The DMS-treated samples
were resolved on a nondenaturing polyacrylamide gel,
and the intramolecularly folded DNA samples were recov-
ered from the gel and subjected to piperidine cleavage. In
the absence of KCl, the DMS methylation pattern of the
guanines along the WT sequence is consistent with an
unstructured DNA form (Figure 2B, lane 3), whereas in
the presence of 100mM KCl, some guanines were well-
protected against DMS methylation, while others showed
enhanced methylation and subsequent cleavage
(Figure 2B, lane 4). The DMS footprinting pattern of
WT in the presence of 100mM KCl demonstrated a sig-
nature for G-quadruplex formation where four tracts of
three guanines (G2–G4, G6–G8, G13–G15 and G17–G19)
form the four strands of a G-quadruplex with a 1:4:1 loop
arrangement (two 1-base loops and one 4-base loop) con-
sisting of C5, C9–G12 and C16, respectively (deﬁned as
G-quadruplex I; Figure 3B). Unexpectedly, G14, which is
located in the run of ﬁve guanines (G11–G15), showed
only modest methylation by DMS, which is consistent
with our previous observation (37).
In an attempt to understand the reactivity mechanism
of G14 to DMS and to extend our previous study (37),
we ﬁrst determined whether the two cytosines in the central
loop(C9 andC10)areinvolved incleavageatG14byform-
ing possible C–G base pairs. Sequences containing C-to-T
or C-to-A mutations (C9T, C9A, C10T and C10A
4600 Nucleic Acids Research, 2008, Vol. 36, No. 14in Table 1A) in the central loop were examined ﬁrst. In the
presence of 100mM KCl, the CD spectra of these
sequences are similar to that of oligonucleotide WT
(data not shown), suggesting that they all form parallel
G-quadruplexes. DMS footprinting results showed that
methylation at G14 still persists (Figure 2B, lanes 6, 8, 10
and 12), with some decrease in oligomers C9T and C10A
compared to the WT sequence. DMS footprinting of an
oligomer with G-to-T mutations at positions 11 and 12
(G11/12T in Table 1A), which forms a parallel G-quad-
ruplex based on CD (data not shown), revealed that
methylation at G14 disappeared (Figure 2C). This experi-
ment demonstrates that the reactivity to DMS at G14 in
the WT sequence is dependent on the presence of the
two guanines in the loop. Thus, this reactivity of G14
to DMS comes from either the alternative use of the ﬁve
consecutive guanines in forming G-quadruplexes
(see below) or other possible interplay among G14,
G11 and G12. However, a clear explanation for the
reactivity of G14 to DMS requires detailed information
on the VEGF G-quadruplex by NMR or X-ray
crystallography.
DMSfootprinting, polymerase stopassayand CD studies
showthat there aretwo equilibrating G-quadruplexloop
isomers, of whichthe 1:4:1 form isthe moststable
In the G-rich strand of the VEGF proximal promoter, the
third run of guanines contains ﬁve guanines (G11–G15),
but only three consecutive guanines are required to form a
G-quadruplex. In principle, diﬀerent loop isomers using
these ﬁve guanines are able to form by using three diﬀer-
ent contiguous guanines, i.e. G11–G13, G12–G14 or
G13–G15. To evaluate this hypothesis, we designed sev-
eral mutant sequences (G11T, G12T, G14T and G14A in
Table 1A). The CD spectra of these four sequences in
the presence of 100mM KCl all demonstrated parallel
G-quadruplex formation (data not shown). In the pres-
ence of KCl, DMS footprinting of G11T and G12T
Figure 2. CD and DMS footprinting of the wild-type VEGF G-rich strand (WT) and other mutant sequences. (A) CD spectrum of WT in the
presence of 100mMKCl. (B) DMS footprinting of WT, C9T, C9A, C10T and C10A in the absence of KCl ( ) or in the presence of 100mMKCl
(+). (C) DMS footprinting of G11/12T. The AG and TC sequencing reactions for WT are shown on the left of (B).
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G13–G15 and G17–G19) are well protected against DMS
methylation and subsequent cleavage, while the other gua-
nines (G1, G12 and G20 in G11T, and G11 and G20 in
G12T) showed enhanced DMS methylation and subse-
quent cleavage (Figure 3A, lanes 2 and 4). Overall, the
G-quadruplex structures formed by these mutants at
the 50-end of the run of ﬁve guanines (G11T and G12T)
use the same three G-tetrads, with a 1:4:1 arrangement of
loops, as those formed by the WT oligomer (deﬁned as
G-quadruplex I; Figure 3B). For sequences G14T and
G14A, we saw a diﬀerent DMS footprinting pattern: the
three contiguous guanines at the 50-end of the third run
of guanines (G11–G13) were well protected against
DMS methylation (Figure 3A, lanes 6 and 8), suggesting
that guanines G11–G13 are involved in G-quadruplex
formation. DMS footprinting of G14T and G14A in the
presence of 100mM KCl demonstrated a pattern of
G-quadruplex formation where G2–G4, G6–G8,
G11–G13 and G17–G19 form the four strands that con-
nect the three tetrads, with a 1:2:3 arrangement of loops
composed of C5; C9 and C10; and G14, G15 and C16,
respectively (deﬁned as G-quadruplex II; Figure 3B).
The stabilities of G-quadruplexes I and II were compa-
red using a polymerase stop assay (Figure 4A).
Very signiﬁcant stop products were seen for the sequences
that form G-quadruplexes using the three guanines at the
30-end (G13–G15) of the ﬁve guanine run with increasing
concentrations of KCl (Figure 4A, Pol-WT, Pol-G11T,
Pol-G12T, Pol-G11/12T), whereas only minor stop
products were observed for the sequences that form
G-quadruplexes using the three guanines at the 50-end
(G11–G13)(Figure4A,Pol-G14TandPol-G14A).Wecon-
clude that the G-quadruplex structure (G-quadruplex I)
Figure 3. (A) DMS footprinting of oligonucleotides G11T, G12T, G14T and G14A in the absence of KCl ( ) or in the presence of 100 mM KCl (+). The
sequence of G11T is shown to the right of the gel. For the other sequences, only the mutated region of G11–G15 is shown. The mutation sites in each
sequence are indicated with an asterisk. (B) The two diﬀerent folding patterns (1:4:1 and 1:2:3) for the VEGF G-quadruplexes inferred from this data.
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which forms a 1:4:1 loop isomer species, is more stable
than the one (G-quadruplex II) formed using the three
50-end guanines (G11–G13). This is further conﬁrmed
by CD melting experiments, which showed that the
G-quadruplex structures with the 1:4:1 loop arrangement
(G11T, G12T, G11/12T) have higher Tm (64–678C versus
57–618C) than the G-quadruplexes with the 1:2:3 loop
arrangement (G14T and G14A) (Figure 4B).
The C-rich strand of theVEGF proximal promoter forms
an intramolecular i-motif structure
To determine whether an i-motif structure is formed by
the C-rich strand of the VEGF proximal promoter, CD
spectra of IM1 (Table 1B), a sequence identical to the
C-rich strand of the VEGF proximal promoter, were col-
lected at diﬀerent pHs. As shown in Figure 5A, at acidic
pH ( 5.9), there is a characteristic positive peak at 288nm
and a negative peak at 265nm, with crossover at 276nm,
indicating the formation of an i-motif structure.
At pH >7, the positive peak sharply decreases, showing
that the i-motif stability decreases with increasing pH.
This indicates that an unstructured DNA forms at neutral
pH due to the deprotonation and the disruption of C–C
+
base-pairing. The transition mid-point pH was determined
to be pH 5.8 by plotting the molar ellipticity at 288nm
versus pHs (Figure 5B).
Native PAGE was used to diﬀerentiate between the for-
mation of intramolecular and intermolecular i-motif struc-
tures (31,40,41). A 24-mer dT oligonucleotide, T24
(Table 1B), was used as a control in this experiment. T24
and IM1 were ﬁrst subjected to electrophoresis on a dena-
turing PAGE gel at pH 8.3, where it was found that IM1
ran as a single band with a similar mobility to T24, which is
similarinsize toIM1(Figure5C).Subsequently,weranthe
same oligomers onanative PAGE gelat pH5.0, conditions
at which IM1 forms an i-motif structure as determined by
CD. The results in Figure 5C show that IM1 travels as one
band faster than T24, suggesting that under acidic condi-
tions, IM1 adopts an intramolecular structure.
If an intramolecular i-motif structure is formed, all four
runs of cytosines should be involved in i-motif formation.
Therefore, mutations within each run of cytosines should
disrupt this formation. To test this, a single C-to-T muta-
tion, double C-to-T mutations or triple C-to-T mutations
were introduced in the middle of runs of three cytosines,
four cytosines or ﬁve cytosines, respectively, to disrupt the
cytosine repeats and determine their involvement in
i-motif formation. CD spectra of these diﬀerent mutant
sequences (IM2–IM5, Table 1B) and IM1at pH 5.5 were
determined. When compared to the CD spectra of IM1,
the i-motif signature peaks (288nm) of IM2–IM5 were all
dramatically decreased (Figure 5D), suggesting that each
run of cytosines contributes to base-pairing during i-motif
formation, which further supports an intramolecular
i-motif formation.
Determination of thecytosines involved inthe formation
ofthe intramolecular i-motif byCD analysis
CD analysis of wild-type and mutant sequences was pre-
viously used to characterize the i-motif structure formed
by the C-rich strand on the 50-end of the Rb gene (34).
Figure 4. (A) Polymerase stop assay of Pol-WT, Pol-G11T, Pol-G12T, Pol-G11/12T, Pol-G14T and Pol-G14A with increasing concentrations of
KCl. The primer site, stop product site and full-length product site are indicated with arrows. Sequencing reactions of guanine for each sequence are
indicated at the top of each lane (G). (B) The polymerase stop assay cassette sequence is shown with a box indicating the diﬀerent G-quadruplex
sequences studied. The primer site and stop site product are shown with arrows. The G-quadruplex sequences are shown below the polymerase stop
assay cassette sequence, with their Tm on the right.
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run contains three cytosines. Therefore, it was assumed
that there would be only three cytosines in each run
involved in the i-motif structure. To identify which three
cytosines are involved in the hemiprotonated C–C
+ pair-
ing of the i-motif, selective C-to-T mutations were intro-
duced at speciﬁc positions on the wild-type C-rich
sequence (IM6–IM12, Table 1B). The CD spectra of
these sequences were collected and compared with that
of IM1. IM6 and IM7 were designed so that the C at
either the 50-end (IM6) or the 30-end (IM7) of the ﬁrst
run of cytosines was mutated to T. The results show
that the mutation at the 30-end (IM7) produces a greater
reduction in molar ellipticity at 288nm in comparison to
the mutation at the 50-end (IM6) (Figure 6A), suggesting
that the C at the 30-end is more important for i-motif
structure formation. Using the same procedure, it was
shown that in the second run of cytosines, the central
three cytosines are more important for i-motif formation
(Figure 6B), and in the fourth run of cytosines, the C at
the 30-end is more critical for i-motif formation
(Figure 6C). On the basis of these results, the cytosines
of IM1 involved in i-motif formation are proposed to be
C2–C4, C7–C9, C13–C15 and C18–C20 (Figure 6D).
Determination of thepredominant i-motif structure
formedby theC-rich strandby Br2footprinting
As we previously reported, Br2 footprinting can be used to
unambiguously determine the identity of the cytosine resi-
dues involved in base pairings and intercalations to form
i-motif structures (35). As shown in Figure 7 (left panel),
lane 3, C2–C4, C7–C9, C13–C15 and C18–C20 are well
protected, suggesting that these cytosines are involved in
base pairing and intercalation, whereas cytosine residues
C6, C10 and C17 showed enhanced reactivity toward Br2,
suggesting that these three residues are located in loop
regions. The cytosines involved in base pairing and inter-
calation determined by Br2 footprinting are the same as
those determined by CD analysis. On the basis of the
results of CD analysis and Br2 footprinting, a model fold-
ing pattern for the VEGF i-motif is proposed, which
involves six hemiprotonated C–C
+ base pairs formed
from four consecutive antiparallel cytosine stretches with
a 2:3:2 loop arrangement (Figure 7, right panel). Since
there are two very narrow grooves and two very wide
grooves in an i-motif (42), we speculate that the two 2-
base loops run across narrow grooves and the 3-base loop
runs across a wide groove. The predominant i-motif
formed by the C-rich strand of the VEGF promoter
adopts an antiparallel i-motif folding pattern similar to
that found in the human telomeric C-strand, as deter-
mined by NMR (42).
DISCUSSION
VEGF is one of the most important angiogenic factors
and is overexpressed in many types of tumors (43).
VEGF and its receptors have been attractive targets for
anti-angiogenesis therapy in the last decade (44). In 2004,
Bevacizumab, a humanized anti-VEGF antibody, was
Figure 5. (A) CD spectra of IM1at room temperature in 50mM Tris–acetate buﬀer at diﬀerent pHs (8.0–4.4). (B) pH dependence of the molar
ellipticity at 288nm from (A). (C) IM1 and T24 on denaturing PAGE gel at pH 8.3 (left) and on a nondenaturing PAGE gel at pH 5.0 (right).
(D) CD spectra of IM1–IM5at pH 5.5.
4604 Nucleic Acids Research, 2008, Vol. 36, No. 14approved by the FDA as a ﬁrst-line therapy for colorectal
cancer treatment, and there now are small-molecule
VEGF receptor inhibitors in diﬀerent stages of clinical
trials (45). Our previous study showed that the polyG/
polyC region in the VEGF proximal promoter is very
dynamic and able to unwind into single-stranded DNA
and then fold into secondary DNA structures, such as
G-quadruplexes (36). In this article, we have partially
characterized the unique DNA secondary structures
formed in the VEGF proximal promoter. The G-rich
strand of the VEGF proximal promoter was shown
to form a parallel G-quadruplex with three G-tetrads
and three double-chain reversal loops containing 1, 4
and 1 bases. From the complementary C-rich strand, an
i-motif is formed with six C–C
+ base pairs and three
loops containing 2, 3 and 2 bases.
The four consecutive runs of guanines in the G-rich
strand of the polyG/polyC tract in the VEGF proximal
promoter have four, three, ﬁve and four guanines, respec-
tively. If three consecutive guanines are randomly selected
from each run of guanines to form a G-quadruplex, twelve
diﬀerent loop isomers could possibly be formed by the
VEGF wild-type G-rich sequence. However, the results
of our study revealed that a 1:4:1 loop isomer is the pre-
dominant conﬁguration formed by this sequence. Results
from the polymerase stop assay show that the 1:4:1 loop
isomer is much more eﬃcient than the 1:2:3 loop isomer in
arresting DNA synthesis (Figure 4A), suggesting that the
1:4:1 loop isomer may be more biologically relevant. The
CD melting experiments conﬁrmed that the 1:4:1 loop
isomer has greater stability (4–108C) than the 1:2:3 loop
isomer (Figure 4B). To enhance the production of the
1:2:3 loop isomer, a mutation is required at G14.
The major folding diﬀerence between these two loop
isomers is that the 1:4:1 loop isomer possesses a G3N1G3
motif on the 30- and 50-ends, in contrast to a single G3N1G3
motif in the 1:2:3 loop isomer. Since it is known that a
double-chain reversal with two edges, each made up of
three guanines and connected through a 1-base loop,
is very stable and is found in a variety of promoter
G-quadruplexes, it is easy to rationalize why the 1:4:1
loop isomer would predominate over the 1:2:3 loop
isomer (23,24,35,36,46–48). While the pathway to the
1:4:1 loop isomer is presumably through the intermediacy
of two distinct 30 and 50 1-base loop faces, we speculate that
the 1:2:3 loop isomer occurs when one 2-base loop forms
directly adjacent to a 1-base loop, thus requiring a 3-base
loop to complete the G-quadruplex.
Figure 6. CD spectra of IM1, IM6 and IM7 (A), IM1 and IM8–IM10
(B) and IM1, IM11 and IM12 (C). The cytosines predicted to be
involved in i-motif formation are underlined (D).
Figure 7. Autoradiogram and densitometric scanning of the autoradio-
gram from a Br2 footprinting experiment to determine cytosine residues
involved in base pairing and intercalation in the intramolecular i-motif
folded form. Lane 1 represents the pyrimidine-speciﬁc reaction used to
generate sequencing marker. Lanes 2 and 3 represent reaction without
and with Br2 (0.5 mM) in double-distilled H2O, respectively. On the
right is shown the predicted folding pattern of the predominant i-motif
structure formed by IM1 based on the results of the Br2 footprinting
experiment shown on the left.
Nucleic Acids Research, 2008, Vol. 36, No. 14 4605The DMS hypersensitivity of G14 is a unique feature of
the VEGF G-quadruplex-forming element. Interpretation
of the DMS footprinting pattern shows that G14 should
reside in the central tetrad of the G-quadruplex. As such,
it was completely unexpected that this guanine would be
hypersensitive to DMS (Figure 2B). This hypersensitivity
is in sharp contrast to the well-protected guanines at the
adjacent positions (13 and 15) and implies that G14 must
exist at some point in a non-Hoogsteen base-paired state,
making this residue more accessible to attack by DMS.
The DMS footprinting results of a series of oligomers
containing mutant VEGF G-rich sequences suggest that
G14 hypersensitivity to DMS is dependent upon the pres-
ence of G11 and G12 (Figure 2C), but not cytosines C9
and C10 (Figure 2B). However, why G14 is hyperreactive
to DMS is not clear at this point, and further biophysical
studies will be required to deﬁne this anomaly.
A small but growing number of promoter elements
that have been shown to form G-quadruplexes, as well
as a more limited number of i-motif-forming sequences,
have been characterized by chemical footprinting and
CD, and in a few cases NMR studies have been carried
out (21,23,35,49–51). For those human promoter elements
that have been shown to be critical for transcrip-
tional activation, it is informative to compare the
G-quadruplex-forming sequences and their folding pat-
terns. The sequences for the 3-tetrad group are shown in
Figure 8A. (Only the predominant G-quadruplex-forming
sequence of each promoter is shown.) The similarities are
striking. All the G-quadruplexes, with the exception of
Bcl-2, have both a 30-a n da5 0-end G3N1G3 motif and
all form parallel G-quadruplex structures (22,24,35). The
exception, Bcl-2, has a 3-base loop at the 50-side and forms
a mixed parallel/antiparallel folding pattern (23,52).
However, what is strikingly diﬀerent in these structures
is the central loop, which diﬀers both in size (2–7 bases)
and base composition.
Outside the class of G-quadruplexes containing three
tetrads are a number of structures that have either two or
four tetrads (Figure 8B). In the case of PDGF-A, there are
four tetrads requiring two bases to form a double-chain
reversal loop on the 30- and 50-sides (49), so this is a
simple incremental variation on the three-tetrad class
that also folds to form parallel G-quadruplexes containing
three double-chain reversal loops. Myb and Rb are com-
posed of only two tetrads, and while Myb still forms a
parallel-stranded G-quadruplex, it requires a heptad on
one face to maintain stability (53). In contrast, the Rb
forms a basket G-quadruplex with a mixed parallel/
antiparallel structure (34).
In addition to that described here for VEGF, folding
patterns for the i-motifs have been assigned for only RET
and Rb, so the data set is more limited (Figure 8C). VEGF
and RET are the same with regard to loop size (2:3:2) but
diﬀer in the number of i-motif C–C
+ hemiprotonated base
pairs, i.e. six for VEGF and ﬁve for RET. Preliminary
modeling studies suggest that the 2:3:2 loop conﬁguration
is the minimum required for bridging the antiparallel runs
of cytosines (unpublished data). Rb conforms to this rule,
having loop sizes of 2:4:2, but in this case only four C–C
+
base pairs, which may also be the minimum required for i-
motif stability. So while the number of C–C
+ base pairs
varies from four to six, the 30- and 50-end lateral-loop
bases are two for each of these i-motifs; but in all cases
the constituent bases in the central lateral loop are
diﬀerent.
The biological role of the i-motif on the C-rich strand in
the VEGF promoter has yet to be determined. Previous
studies from the Levens lab have shown that heteroge-
neous nuclear ribonucleoprotein K (hnRNP K) is able
to bind to the C-rich strand, called the CT element, in
the NHE III1 region of the c-Myc oncogene promoter
to activate c-Myc transcription (54,55). Therefore, the
formation of an i-motif structure on the C-rich strand of
the VEGF promoter could prevent hnRNP K binding to
the single-strand to activate transcription. Thus, i-motif
formation on the C-rich strand could be a silencing
element for DNA transcriptional regulation.
Finally, we have also observed that G-quadruplex-
interactive agents are able to stabilize the VEGF
G-quadruplex in vitro and downregulate VEGF mRNA
levels in cancer cells (37), suggesting that targeting the
G-quadruplex formed in the VEGF promoter is a feasible
strategy to modulate VEGF expression at the transcrip-
tional level. Therefore, targeting DNA secondary struc-
tures in the VEGF promoter could be a novel approach
to anti-angiogenesis drug discovery in cancer therapy.
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